Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which blood pressure drug works best after stroke surgery?

NCT ID NCT07364201

Disease control Sponsor: Universitas Sumatera Utara Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 30 adults who had brain surgery after a hemorrhagic stroke and needed blood pressure control in the ICU. Researchers compared two IV medicines, nicardipine and labetalol, to see which one better controlled blood pressure and heart rate during the first 24 hours. The goal is to help doctors choose the best drug to prevent complications like re-bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Nov 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years old). * Diagnosed with hemorrhagic stroke. * Undergoing craniotomy for hemorrhagic stroke. * Admitted to the intensive care unit after surgery. * Require intravenous antihypertensive therapy for postoperative blood pressure control. * Invasive arterial blood pressure monitoring in place. * Written informed consent obtained from the patient or legally authorized representative. Exclusion Criteria: * Known hypersensitivity or contraindication to nicardipine or labetalol. * Severe bradycardia, advanced atrioventricular block, or uncontrolled heart failure. * History of bronchial asthma or severe chronic obstructive pulmonary disease. * Hemodynamic instability requiring vasopressor support at enrollment. * Pregnancy or breastfeeding. * Participation in another interventional clinical study during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemodynamic instability are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemorrhagic stroke hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemodynamic instability Hemorrhagic strokes Postoperative hypertension

Contacts and locations

Locations

  • Adam Malik Hospital, Haji Hospital Medan

    Medan, North Sumatera, 20146, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.